Gen-Probe Gets FDA OK for Human Adenovirus Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe said after the close of the market Wednesday that its Prodesse subsidiary has received US Food and Drug Administration clearance for its ProAdeno+ assay for qualitative detection of human adenovirus.

The test uses real-time PCR to detect human adenovirus DNA in nasopharyngeal specimens obtained from people exhibiting signs and symptoms of acute respiratory infection. It can detect but not differentiate among adenovirus serotypes 1-51, said Gen-Probe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.